Last reviewed · How we verify

Curcumin (Turmeric) — Competitive Intelligence Brief

Curcumin (Turmeric) (Curcumin (Turmeric)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Natural polyphenol / anti-inflammatory agent. Area: Inflammation, Oncology, Gastrointestinal, Rheumatology.

phase 3 Natural polyphenol / anti-inflammatory agent NF-κB, multiple cytokines (TNF-α, IL-6, IL-8), reactive oxygen species Inflammation, Oncology, Gastrointestinal, Rheumatology Small molecule Live · refreshed every 30 min

Target snapshot

Curcumin (Turmeric) (Curcumin (Turmeric)) — Services Institute of Medical Sciences, Pakistan. Curcumin inhibits multiple inflammatory pathways and transcription factors, particularly NF-κB, reducing pro-inflammatory cytokine production and oxidative stress.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Curcumin (Turmeric) TARGET Curcumin (Turmeric) Services Institute of Medical Sciences, Pakistan phase 3 Natural polyphenol / anti-inflammatory agent NF-κB, multiple cytokines (TNF-α, IL-6, IL-8), reactive oxygen species

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Natural polyphenol / anti-inflammatory agent class)

  1. Services Institute of Medical Sciences, Pakistan · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Curcumin (Turmeric) — Competitive Intelligence Brief. https://druglandscape.com/ci/curcumin-turmeric. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: